Cellectar Biosciences Inc.

Discussion in 'Penny Stocks' started by David Malan, Nov 18, 2016.

  1. Johncmartin

    Johncmartin New Member

    Joined:
    Nov 17, 2016
    Messages:
    6
    Likes Received:
    2
    In both August and September, CLRB received non-dilutive funding in the form of grants and contract awards totaling $14 million dollars. Two million dollars was awarded from the National Cancer Institute SBIR and an additional $12 million from the University of Wisconsin. These grants demonstrate the significance and relevance of the PDC platform and of the potential of the CLR-131 program.
     
  2. douglashall007

    douglashall007 New Member

    Joined:
    Nov 17, 2016
    Messages:
    10
    Likes Received:
    1
    So as per the August and September Reports of the stock and the present status we see that dilution does not have a very drastic effect on the stock. Hence it is quite a stable stock
     
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    HAHAHA!

    Yeah ok.

    a) Tell you what, drop the other aliases and we let you stay and you can talk about this stock like a normal person.

    or

    b) Continue posting under several aliases and we just ban them all.

    You decide.
     
    Stockaholic likes this.
  4. douglashall007

    douglashall007 New Member

    Joined:
    Nov 17, 2016
    Messages:
    10
    Likes Received:
    1
    The results of the Presidential Elections will have favoring results for the company as the company is expecting new policies by President Trump that will benefit them and thus increase the valuation on the stock
     

Share This Page